Source: Eur Respir J 2005; 25: 834-842
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Lepetit H., Eddahibi S., Fadel E., Frisdal E., Munaut C., Noel A., Humbert M., Adnot S., D'Ortho M-P., Lafuma C.. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension. Eur Respir J 2005; 25: 834-842

Member's Comments

No comment yet.

Related content which might interest you: Matrix metalloproteinases and their inhibitors in pulmonary hypertension}, Source: Eur Respir J 2012; 40: 766-782 Year: 2012 Extracellular matrix components and regulators in the airway smooth muscle in asthma Source: Eur Respir J 2008; 32: 61-69 Year: 2008 Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension Source: Eur Respir J 2001; 18: 838-845 Year: 2001 Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002 Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Effects of cyclic stretch on stiffness and matrix metalloproteinases (MMPs) in mouse lung tissue strips Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis Year: 2009 Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Matrix metalloproteinases in pulmonary fibrosis Source: Annual Congress 2013 –Regulation of lung inflammation and repair by proteolysis Year: 2013 Pathobiology of pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1559-1572 Year: 2002 Role of endothelin in lung fibrosis Source: Eur Respir Rev 2008; 17: 145-150 Year: 2008 The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007 Metalloproteinases in idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 38: 1461-1467 Year: 2011 Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases expression in the bronchial secretions of asthmatics and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 92s Year: 2002 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Effects of neurotrophins on matrix metalloproteinase production in human bronchial smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 128s Year: 2005 Statins inhibit matrix metalloproteinase release from human lung fibroblasts Source: Eur Respir J 2010; 35: 637-646 Year: 2010 Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004 Matrix metalloproteinases in COPD Source: Eur Respir J 2012; 39: 197-209 Year: 2012